CYTK
Cytokinetics, Incorporated
Stock
$65.62−0.29 (−0.44%)Close Oct 1, 2026
| Operating cash flow (TTM) |
|---|
| −$555M |
| Operating cash flow (TTM) | −$555M |
|---|
Operating cash flow
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | −$510M | — |
| 2024 | −$396M | — |
| 2023 | −$414M | — |
| 2022 | −$300M | — |
| 2021 | −$143M | — |
| 2020 | $8.9M | — |
| 2019 | −$91M | — |
| 2018 | −$101M | — |
| 2017 | −$102M | — |
| 2016 | $37M | +657.4% |
| 2015 | $4.9M | — |
| 2014 | −$45M | — |
| 2013 | −$7.7M | — |
| 2012 | −$33M | — |
| 2011 | −$46M | — |
| 2010 | −$45M | — |
| 2009 | $8.4M | — |